The next generation molecular assays utilized in the Spiro Stat Lyme and Fungi panels are basically universal for all bacterial and fungal pathogens. This universal nature is not possible with assays based on the detection of antigens, antibodies, or metabolites generated by the host immune system or the organism. Most scientists consider molecular diagnostics the best testing method because of the potential for: